Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine vs Pregabalin in DPNP
NCT02417935Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of duloxetine in diabetic polyneuropathy (DPN), sponsored by Eli Lilly and Company. Started Apr 2015; status: completed.
02
Drugs
duloxetine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT02417935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417935.